Capital International Investors’s Elevance Health ELV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.52B | Buy |
6,488,029
+932,142
| +17% | +$362M | 0.43% | 58 |
|
|
2025
Q1 | $2.42B | Buy |
5,555,887
+1,675,257
| +43% | +$729M | 0.48% | 55 |
|
|
2024
Q4 | $1.43B | Buy |
3,880,630
+35,576
| +0.9% | +$13.1M | 0.27% | 86 |
|
|
2024
Q3 | $2B | Buy |
3,845,054
+112,079
| +3% | +$58.3M | 0.38% | 70 |
|
|
2024
Q2 | $2.02B | Buy |
3,732,975
+234,464
| +7% | +$127M | 0.42% | 63 |
|
|
2024
Q1 | $1.81B | Buy |
3,498,511
+123,802
| +4% | +$64.2M | 0.37% | 79 |
|
|
2023
Q4 | $1.59B | Buy |
3,374,709
+248,150
| +8% | +$117M | 0.36% | 77 |
|
|
2023
Q3 | $1.36B | Sell |
3,126,559
-1,564,746
| -33% | -$682M | 0.35% | 81 |
|
|
2023
Q2 | $2.08B | Sell |
4,691,305
-155,005
| -3% | -$68.9M | 0.5% | 58 |
|
|
2023
Q1 | $2.23B | Sell |
4,846,310
-636,068
| -12% | -$292M | 0.57% | 46 |
|
|
2022
Q4 | $2.81B | Sell |
5,482,378
-1,188,375
| -18% | -$610M | 0.75% | 29 |
|
|
2022
Q3 | $3.03B | Buy |
6,670,753
+248,354
| +4% | +$113M | 0.88% | 26 |
|
|
2022
Q2 | $3.1B | Buy |
6,422,399
+150,575
| +2% | +$72.7M | 0.84% | 27 |
|
|
2022
Q1 | $3.08B | Buy |
6,271,824
+633,661
| +11% | +$311M | 0.7% | 35 |
|
|
2021
Q4 | $2.61B | Buy |
5,638,163
+437,816
| +8% | +$203M | 0.55% | 44 |
|
|
2021
Q3 | $1.94B | Buy |
5,200,347
+577,145
| +12% | +$215M | 0.44% | 62 |
|
|
2021
Q2 | $1.77B | Buy |
4,623,202
+258,720
| +6% | +$98.8M | 0.4% | 70 |
|
|
2021
Q1 | $1.57B | Buy |
4,364,482
+180,270
| +4% | +$64.7M | 0.4% | 69 |
|
|
2020
Q4 | $1.34B | Sell |
4,184,212
-587,828
| -12% | -$189M | 0.37% | 79 |
|
|
2020
Q3 | $1.28B | Sell |
4,772,040
-2,751,913
| -37% | -$739M | 0.4% | 66 |
|
|
2020
Q2 | $1.98B | Sell |
7,523,953
-594,186
| -7% | -$156M | 0.65% | 38 |
|
|
2020
Q1 | $1.84B | Buy |
8,118,139
+1,139,145
| +16% | +$259M | 0.75% | 33 |
|
|
2019
Q4 | $2.11B | Buy |
6,978,994
+1,298,029
| +23% | +$392M | 0.72% | 33 |
|
|
2019
Q3 | $1.36B | Buy |
5,680,965
+1,934,596
| +52% | +$464M | 0.52% | 55 |
|
|
2019
Q2 | $1.06B | Buy |
3,746,369
+2,269,533
| +154% | +$640M | 0.42% | 68 |
|
|
2019
Q1 | $424M | Buy |
+1,476,836
| New | +$424M | 0.18% | 128 |
|